Compound: 353-09-3
SMILES: O=C(O)CCNC(=N)N
InChIKey: KMXXSJLYVJEBHI-UHFFFAOYSA-N
Synonyms: 353-09-3, beta-Guanidinopropionic acid, Guanidinopropionic acid, Ompenaclid, 3-carbamimidamidopropanoic acid, beta-GPA, amidino beta-alanine, N-(Aminoiminomethyl)-beta-alanine, ORISTAR GPA, PNU-10483, RGX202, UL1984YRKA, Rgx 202, DTXSID40188795, 3-((diaminomethylidene)amino)propanoic acid, 3-[(diaminomethylidene)amino]propanoic acid, beta-guanidine propionic acid, RefChem:782874, SLC6A8 Inhibitor RGX-202, DTXCID00111286, 206-530-0, RGX-202-01, 3-Guanidinopropionic acid, 3-guanidinopropanoic acid, 3-Guanidinopropanoate, RGX-202, 3-(diaminomethylideneamino)propanoic acid, MFCD00045939, b-Alanine, N-(aminoiminomethyl)-, Beta-Guanadinopropionate, 3-guanidinopropanoicacid, 3-Guanidino-propionic acid, CHEMBL20489, A1D9S, N-(Aminomethyl)-beta-alanine, EINECS 206-530-0, |A-Guanidinopropionic acid, UNII-UL1984YRKA, ompenaclid [INN], b-Guanidinopropionate, guanidinepropanoicacid, guanidinopropionicacid, guanidinopropionic-acid, n-amidino-beta-alanin, Guanidinoproprionic-beta, Ompenaclid [WHO-DD], Ompenaclid (USAN/INN), OMPENACLID [USAN], 3-Guanidinopropionic acid?, ss--Guanidinopropionic acid, N-carbamimidoyl-beta-alanine, SCHEMBL33761, SCHEMBL66712, beta-Guanidinopropionic acid., .beta.-Guanidinopropionic acid, AMIDINO .BETA.-ALANINE, N-carbamimidoyl-.beta.-alanine, GTPL4707, orb1299731, n-(aminoiminomethyl)beta-alanine, CHEBI:15968, n-(aminoiminomethyl)-beta-alanin, |A-GPA,PNU 10483, dl-.beta.-Guanidino propionic acid, N-(Diaminomethylidene)-beta-alanine, 3-(carbamimidoylamino)propanoic acid, BDBM50021610, beta-Alanine, N-(aminoiminomethyl)-, EBC-50068, N-[Amino(imino)methyl]-beta-alanine, PDSP1_000138, PDSP2_000137, RGX-202; 3-Guanidinopropionic acid, AKOS006223011, CS-W016544, FG38106, GS-6269, HY-W015828, .beta.-Alanine, N-(aminoiminomethyl)-, N-[Amino(imino)methyl]-beta-alanine #, SY066704, DB-006453, A3421, NS00029831, EN300-61035, C03065, D12779, H10255, F242928, Q5613765, 3-Guanidinopropionic acid, puriss., >=99.0% (NT), BRD-K50781608-001-02-1, Z959165114
Theoretical properties:
molecular_formula: C4H9N3O2
molecular_weight: 131.13 g/mol
exact_mass: 131.069476538 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 3
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 3
heavy_atom_count: 9
topological_polar_surface_area: 102 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: 3-guanidinopropanoic acid is a guanidine compound bearing an N-(2-carboxyethyl) substituent. It is a creatine analogue that has been found to decreases plasma glucose levels. It has a role as a hypoglycemic agent. It is functionally related to a propionic acid. It is a tautomer of a 3-guanidinopropanoic acid zwitterion.
chebi: A guanidine compound bearing an <em>N</em>-(2-carboxyethyl) substituent. It is a creatine analogue that has been found to decreases plasma glucose levels
chembl: OMPENACLID is a small molecule listed in the ChEMBL database and has reached clinical trial phase 2.0.
wikipedia: 3-Fluoroamphetamine (3-FA; PAL-353) is a stimulant drug from the amphetamine family which acts as a monoamine releaser with similar potency to methamphetamine but more selectivity for dopamine and norepinephrine release over serotonin. It is self-administered by mice to a similar extent to related drugs such as 4-fluoroamphetamine and 3-methylamphetamine.
3-Fluoroamphetamine has been used as a designer drug in several studies to mimic the effects of illegal amphetamines. It has also appeared on the drug market for recreational use as an amphetamine alternative, as was reported in January 2009 to the European Early Warning System by Belgium. Little is known about the exact history of this compound.